• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Weakness (1967); Undesired Nerve Stimulation (1980); Blurred Vision (2137); Loss of consciousness (2418); Diaphoresis (2452); Convulsion/Seizure (4406); Presyncope (4410); Syncope/Fainting (4411)
Event Date 07/21/2021
Event Type  Injury  
Event Description
It was reported the patient experienced a severe epileptic seizure.The patient was hospitalized and given antiepileptic therapy in the form of valproate, and stimulation was turned off.The patient has recovered, and the physician assessed the event as not related to the procedure, possibly related to stimulation, and unlikely related to the hardware.
 
Manufacturer Narrative
Additional suspect medical device components involved in the event: product family: dbs-linear leads, upn: m365db2202450, model: db-2202-45, serial: (b)(6), batch: (b)(6).
 
Event Description
It was reported the patient experienced a severe epileptic seizure.The patient was hospitalized and given antiepileptic therapy in the form of valproate, and stimulation was turned off.The patient has recovered, and the physician assessed the event as not related to the procedure, possibly related to stimulation, and unlikely related to the hardware.Additional information received stated the patient first experienced a pre-syncopal episode with blurred vision, sweating and intense asthenia.On the same day, the patient presented to the emergency room (er) and experienced a syncopal episode with a non-continuous feeling described as brain shocks.Later that day the patient experienced a generalized tonic-clonic seizure lasting approximately 30 seconds.After a postictal phase, the patient regained consciousness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key12285363
MDR Text Key265350869
Report Number3006630150-2021-04318
Device Sequence Number1
Product Code NHL
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/26/2023
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7081564
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/26/2021
Initial Date FDA Received08/05/2021
Supplement Dates Manufacturer Received08/10/2021
Supplement Dates FDA Received08/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-